Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2020

View Archived Issues

BMS details discovery and preclinical study of pulmonary fibrosis candidate BMS-986278

Blood substitution therapy expands therapeutic time window for stroke

iBET you I can kill those metastases

Elite controller achieves none-in-a-billion status

Efficacy and mechanism of action of novel DNA gyrase inhibitors against mycobacteria

Preclinical results suggest erectile dysfunction drugs can be repurposed to treat osteoporosis

FDA clears IND for global phase II study of CS-1001 for relapsed or refractory ENKTL

Cyprium reports topline clinical data for CUTX-101 in Menkes disease

Janssen Biotech patents DHODH inhibitors

U.S. researchers disclose new bacterial MenE inhibitiors

Skyhawk Therapeutics identifies small molecule splicing modulators for cancer

FDA expands EUA for Veklury to include hospitalized patients with mild or moderate COVID-19

Canwell Biotech synthesizes new TLR agonists

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Data presented on PF-05221304 and PF-06865571 coadministration in NAFLD patients

IIIM-290 development for treating pancreatic cancer advances into the clinic

TRILOGY 2 study of CaPre in severe hypertriglyceridemia does not meet primary endpoint

Akari details plans to develop nomacopan for COVID-19 pneumonia

Can-Fite's IND for phase II study of piclidenoson to treat COVID-19 cleared by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...